In the inflammatory cells of human laryngeal carcinoma tissue samples, ANXA1/FPR2 expression was markedly exacerbated; however, in laryngeal carcinoma cells, this expression was down-regulated. This evidence concerns the gene FPR2 and laryngeal carcinoma.